Pilot Study on Lung Cancer Screening Implementation Among Employees at Lyon Hospital
Trial Snapshot
- Phase
- Not Applicable
- Status
- Recruiting
- Sponsor
- Hospices Civils de Lyon
- Enrollment
- 600
- Locations
- 4
- Primary Endpoint
- Participation rate at baseline
Study Overview
Brief Summary
Several randomized studies have demonstrated the efficiency of lung cancer screening (LCS) on mortality rates. However, screening efficiency is related to the targeted population and the participation rate.
In France, the participation rate for breast and colon cancer screening programs is respectively 50% and 32%, which is low. Then, it appears very important to determine which factors are influencing the willingness to participate to these programs. Indeed, it will allow a better communication and we will be able to perform screening campaigns adapted to the eligible population.
The Lyon Hospital is the second university hospital in France. It is composed of 14 buildings and employed 23 000 persons. More than 160 occupations are represented. So, hospital employees look relevant to be studied for LCS program.
ILYAD was divided in 2 parts. The first one was completed in 2020 and goal to evaluate the number of eligible individuals among the hospital employees. About 800 persons would be eligible for LCS.
This second part of the study will evaluate the participation rate and the feasibility of the LCS program. The study will target the 800 individuals that were identified previously.
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Intervention Model
- Single Group
- Primary Purpose
- Diagnostic
- Masking
- None
Eligibility Criteria
- Ages
- 50 Years to 75 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Participation rate at baseline
Time Frame: At the baseline visit
Ratio between the number of participants who underwent a CT scan at baseline and the estimated number of eligible employees
Secondary Outcomes
- Evaluate the participation rate at 1 year and identify the factors that trigger it.(At 1Year follow-up)
- Evaluation of the efficiency of VOC for LC screening(At baseline)
- Participation rate according to the 3 communication levels.(At 4 month = level 1 ; At 8 month = level 2 ; At 12 month = level 3)
- Evaluation of feasibility of the LCS program by measuring the proportion of individuals having undergo all the required exams and evaluations according to the results of the CT scan, conformity of the scan interpretation, and adverse event monitoring.(At baseline and At 1Year follow-up)
- Identification of efficient biomarker for LC screening(At baseline)
- Identification of predictive factors for participation decision(At baseline and At 1Year follow-up)
- Evaluation of screening efficiency according to the proportion of lung cancer, ILD, COPD diagnosed and the percentage of smoking cessation among the active smokers.(At baseline and At 1Year follow-up)
- Evaluate the follow up to the french guidelines(Follow up after the 1 year visit)